.png)
NOBIOTICS AND THE TEAM IN THE NEWS
NOBiotics and its dedicated team continue to make significant strides in pioneering innovative solutions for regenerative medicine and antimicrobial therapies. From advancing nitric oxide-integrated biomaterials to tackling critical challenges in wound healing and tissue transplantation, our efforts are driving transformative change in healthcare. With groundbreaking research, strategic collaborations, and a commitment to innovation, we are not only pushing scientific boundaries but also bringing hope to patients in need. Every milestone achieved is a step closer to real-world impact, and we are grateful for the unwavering support that fuels our mission to revolutionize treatment possibilities. Stay tuned—exciting breakthroughs are on the horizon!
NOBiotics Joins the 2025 BioNC Hotbed Maps by BioSpace!
Feb' 7, 2025
We are incredibly honored to be featured in the 2025 BioNC Hotbed Map by BioSpace! This recognition celebrates life sciences companies poised for breakthrough innovation and growth. Being listed alongside industry leaders like Novo Nordisk, BioAgilityx, GSK, and Duke is a testament to our commitment to advancing healthcare solutions.
We’re excited for the journey ahead and grateful for the support of our team, collaborators, and community!
NOBiotics Ranked Among Top 10 Technologies in the Fight Against AMR by NIAMRRE
March, 2025
We’re thrilled to announce that NOBiotics has been recognized among the Top 10 groundbreaking antimicrobial resistance (AMR) technologies in the U.S. by the National Institute of Antimicrobial Resistance Research and Education (NIAMRRE). This honor highlights our commitment to developing nitric oxide-based solutions to combat drug-resistant infections. We're proud to stand alongside other innovators in the fight against one of the most pressing global health threats.
NOBiotics Team is Selected in the NIH Bootcamp!
Jan' 17, 2025
We're thrilled to share that NOBiotics has been selected for the prestigious NIH Entrepreneurial Cohort in partnership with VentureWell! A special shoutout to Martin Tran, our Scientific Lead, for driving this forward with his visionary leadership and expertise.
This recognition underscores our commitment to innovation, collaboration, and transformative healthcare solutions. Congratulations to Martin for making this milestone possible!
Ms. Sapna Hornyak Joins NOBiotics' Advisory Board
Nov' 15, 2024
We are beyond thrilled to announce that Sapna Hornyak, former President & CEO of Avania, is joining NOBiotics! With over 20 years of executive leadership in clinical trials, regulatory strategy, and global commercialization, Sapna brings unparalleled expertise and vision to our team. Her strategic insights and industry leadership will be instrumental in shaping the future of NOBiotics as we advance groundbreaking innovations in healthcare. Join us in welcoming Sapna to the NOBiotics family—her impact will be nothing short of extraordinary!
Mr. Steve Keiser Joins NOBiotics Advisory Board!
Aug' 12, 2024
We are excited to announce that Steve Keiser, former CEO and President of Caron Scientific, has joined the NOBiotics Advisory Board! With over 40 years of experience in biotechnology, strategic growth, and global R&D leadership, Steve brings invaluable expertise to NOBiotics. His exceptional track record in advancing biopharmaceutical companies, driving mergers and acquisitions, and spearheading product innovations will provide critical guidance as we continue to grow and innovate. Steve’s insights and leadership will be pivotal as we advance our mission to revolutionize healthcare solutions. We’re honored to have him on board and look forward to the incredible impact we’ll make together!
NOBiotics Advances to the Next Round of NSF’s America’s Seed Fund!
July 01, 2024
In less than a month since our foundation, NOBiotics has reached a significant milestone—our project pitch has been accepted for the next round by the National Science Foundation (NSF) America’s Seed Fund! This achievement highlights the impact of our innovation and fuels our commitment to transforming healthcare. A heartfelt thank you to our supporters—this is just the beginning of an exciting journey ahead!
NOBiotics Welcomes Ms. Maria Thacker Goethe as Strategic Advisor!
June 7, 2024
We are thrilled to welcome Maria Thacker Goethe to the NOBiotics team as our new Advisor for Strategic Partnerships & Collaboration. A true visionary in global health and biosciences, Maria has been instrumental in transforming Georgia Bio into one of the state’s most influential associations, driving growth and innovation in the bioscience and MedTech sectors. Her unparalleled expertise in alliance building, cross-sector collaboration, and strategic vision, combined with leadership roles including a fellowship at the CDC and recognition as one of the "100 Most Influential Georgians," make her a tremendous asset to our mission. With Maria’s guidance, NOBiotics is poised to make even greater strides in shaping the future of healthcare
When Dr. Jitendra Pant, Founder and CEO of NOBiotics, Received a Surprise Visit from CDC (former) Director Dr. Robert Redfield
2019
In 2019, in a remarkable turn of events, Dr. Jitendra Pant, the visionary founder of NOBiotics, received an unexpected visit from Dr. Robert Redfield, the former Director of the CDC. The visit was to acknowledge Dr. Pant’s groundbreaking research on Nitric Oxide and its transformative potential in healthcare. This encounter would go on to plant the seeds for NOBiotics, propelling our mission to drive healthcare innovation forward. It was a significant milestone in our journey, symbolizing the growing impact of Dr. Pant’s research and the increasing recognition of NOBiotics in the global scientific community.